InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Collins Cooper C.. Officer active across 1 companies, notably TherapeuticsMD, Inc.. Cumulatively, 6 disclosures have been logged. Total volume traded: €1.2m. The latest transaction was filed on 18 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€510,9891,000,000 shares@ €0.5112.21% mcap88.6% of flow
Common Stock
SEC:0001209191-21-066002·
Ideal exit: 15 Aug 2022 (T+270)
€510,9891,000,000 shares@ €0.5112.21% mcap44.3% of flow
Common Stock
SEC:0001209191-21-066002:0·
Ideal exit: 15 Aug 2022 (T+270)
€65,757100,000 shares@ €0.65760.28% mcap11.4% of flow
Common Stock
SEC:0001387131-21-008733·
Ideal exit: 14 May 2022 (T+270)
€65,757100,000 shares@ €0.65760.28% mcap5.7% of flow
Common Stock
SEC:0001387131-21-008733:0·
Ideal exit: 14 May 2022 (T+270)
96,864 shares
Common Stock
SEC:0001387131-21-008436·
96,864 shares
Common Stock
SEC:0001387131-21-008436:0·
6 of 6 declarations
About Collins Cooper C.
Collins Cooper C. is a director at TherapeuticsMD, Inc.
